Medicamen Biotech Limited has informed the Exchange about Copy of Newspaper Publication
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medicamen Biotech Limited has disclosed the publication of its audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. The Board of Directors approved these results at their meeting held on May 27, 2026. The results were published in Financial Express and Jansatta newspapers on May 28, 2026, as required under SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. This filing is a procedural regulatory compliance document - it only provides notice that results were published in newspapers. The actual financial figures (revenue, profit, EPS, etc.) are not included in this filing and are available on the company's website.
This is a standard mandatory disclosure with no immediate stock impact. Investors should refer to the actual financial results posted on the company's website (www.medicamen.com) to evaluate Q4 and full-year performance. The newspaper publication format typically contains only key highlights, not detailed financials.